Skip to content

Author

Mohamed Hassan

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Clinical trial Open access Sep 2026

Evaluation of Maintenance Capecitabine Therapy After First-Line Chemotherapy in Metastatic Pancreatic Cancer.

Maintenance capecitabine after first-line modified FOLFIRINOX in patients with metastatic pancreatic cancer was well tolerated and may enhance PFS and OS while maintaining an acceptable quality of life.

M. Shehata, A. Alhanafy, Mohamed Hassan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.